Rachel Capone, MSHS
Advertisement
Rachel Capone, MSHS, is a regulatory affairs manager, Syner-G BioPharma Group.
Articles by Rachel Capone, MSHS
Advertisement
Latest Updated Articles
Unlocking the Benefits of FDA’s Orphan Drug DesignationPublished: August 22nd 2023 | Updated:
Advertisement
Advertisement
Trending on AJMC
1
As Cencora Closes With OneOncology, Patton Says Terms Show “Trust”
2
TrumpRx Launch Brings Savings—and Uncertainty
3
Exploring Identity, Appearance Experiences Among Patients With Alopecia
4
Benefits, Tradeoffs of Medically Integrated Dispensing in Oncology Care: Katherine Tobon, PharmD, BCOP
5
